FDA Pushes Clinical Trial Transparency in 2026
Nearly 30% of clinical trials required to report results never submitted data to ClinicalTrials.gov, prompting FDA enforcement letters in April 2026.
FDA enforcement
2 articles tagged "FDA enforcement"
FDA Targets Telehealth GLP-1 Compounders in 2026 Crackdown
FDA has warned 70+ telehealth companies over compounded GLP-1 drugs, with scrutiny now extending to affiliated medical groups and prescribing networks.
By Robert Kim